1-2 of 2
Tomoaki Hoshino
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity

Free
Tokiyoshi Tanegashima, Yosuke Togashi, Koichi Azuma, Akihiko Kawahara, Ko Ideguchi, Daisuke Sugiyama, Fumio Kinoshita, Jun Akiba, Eiji Kashiwagi, Ario Takeuchi, Takuma Irie, Katsunori Tatsugami, Tomoaki Hoshino, Masatoshi Eto, Hiroyoshi Nishikawa
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (15): 4808–4819.
https://doi.org/10.1158/1078-0432.CCR-18-3991
Published: 01 August 2019
View articletitled, Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity
Open the PDF for Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer

Free
Keiichi Ota, Koichi Azuma, Akihiko Kawahara, Satoshi Hattori, Eiji Iwama, Junko Tanizaki, Taishi Harada, Koichiro Matsumoto, Koichi Takayama, Shinzo Takamori, Masayoshi Kage, Tomoaki Hoshino, Yoichi Nakanishi, Isamu Okamoto
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 4014–4021.
https://doi.org/10.1158/1078-0432.CCR-15-0016
Published: 31 August 2015
View articletitled, Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer
Open the PDF for Induction of PD-L1 Expression by the EML4–ALK Oncoprotein and Downstream Signaling Pathways in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data